UK launch for Nordic’s novel methotrexate pen
Nordic Pharma has launched Nordimet – the first button-free, once-weekly PEN device containing the active substance methotrexate – across the UK, offering patients with various auto-immune conditions a new means of administering treatment with a Disease Modifying Anti-Rheumatic Drug (DMARD).
Read More
